Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (811-820 of 1,095) with videos related to

Pageof 110
Sort By:
Alimentary Pharmacology & Therapeutics|September 4, 2020
Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosisMilan J Sonneveld, Willem P Brouwer, Bettina E Hansen, et al.
Oncotarget|December 17, 2017
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysisDaniele Santini, Raffaele Ratta, Francesco Pantano, et al.
Clinical Genitourinary Cancer|May 28, 2018
Is It Possible to Improve Prognostic Classification in Patients Affected by Metastatic Renal Cell Carcinoma With an Intermediate or Poor Prognosis?Roberto Iacovelli, Ugo De Giorgi, Luca Galli, et al.
Annals of Hepatology|October 4, 2025
A multinational survey of physician knowledge about management of chronic hepatitis CMohamed El-Kassas, Yusuf Yilmaz, Chun-Jen Liu, et al.
Annals of Surgical Oncology|December 5, 2014
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitorsMatteo Santoni, Alessandro Conti, Stefano Partelli, et al.
Urologic Oncology|April 3, 2019
The effect of a treatment delay on outcome in metastatic renal cell carcinomaRoberto Iacovelli, Luca Galli, Ugo De Giorgi, et al.
American Journal of Human Genetics|May 15, 2024
Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variationZhi Ming Xu, Gnimah Eva Gnouamozi, Sina Rüeger, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2023
Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis eliminationJordi Llaneras, Juan Carlos Ruiz-Cobo, Ariadna Rando-Segura, et al.
Minerva Urology and Nephrology|December 13, 2022
A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA ScoreGiuseppe Fornarini, Sara E Rebuzzi, Sebastiano Buti, et al.
Journal of Hepatology|December 3, 2015
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patientsW Ray Kim, Thomas Berg, Tarik Asselah, et al.
Pageof 110

Showing results (811-820 of 1,095) with videos related to

Sort By:
Pageof 110
Alimentary Pharmacology & Therapeutics|September 4, 2020
Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosisMilan J Sonneveld, Willem P Brouwer, Bettina E Hansen, et al.
Oncotarget|December 17, 2017
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysisDaniele Santini, Raffaele Ratta, Francesco Pantano, et al.
Clinical Genitourinary Cancer|May 28, 2018
Is It Possible to Improve Prognostic Classification in Patients Affected by Metastatic Renal Cell Carcinoma With an Intermediate or Poor Prognosis?Roberto Iacovelli, Ugo De Giorgi, Luca Galli, et al.
Annals of Hepatology|October 4, 2025
A multinational survey of physician knowledge about management of chronic hepatitis CMohamed El-Kassas, Yusuf Yilmaz, Chun-Jen Liu, et al.
Annals of Surgical Oncology|December 5, 2014
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitorsMatteo Santoni, Alessandro Conti, Stefano Partelli, et al.
Urologic Oncology|April 3, 2019
The effect of a treatment delay on outcome in metastatic renal cell carcinomaRoberto Iacovelli, Luca Galli, Ugo De Giorgi, et al.
American Journal of Human Genetics|May 15, 2024
Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variationZhi Ming Xu, Gnimah Eva Gnouamozi, Sina Rüeger, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2023
Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis eliminationJordi Llaneras, Juan Carlos Ruiz-Cobo, Ariadna Rando-Segura, et al.
Minerva Urology and Nephrology|December 13, 2022
A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA ScoreGiuseppe Fornarini, Sara E Rebuzzi, Sebastiano Buti, et al.
Journal of Hepatology|December 3, 2015
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patientsW Ray Kim, Thomas Berg, Tarik Asselah, et al.
Pageof 110